L-Alanyl-L-Glutamine

L-Alanyl-L-Glutamine

Form: Sterile intravenous (IV) infusion solution

Strength: 20% solution (200 mg/mL)

Reference Brands: Dipeptiven®(EU & Global)

Category: Critical Care

L-Alanyl-L-Glutamine is a stable dipeptide used in parenteral nutrition to supply glutamine, a conditionally essential amino acid vital for gut integrity, immune support, and nitrogen transport. Available as a 20% IV infusion (200 mg/mL), it is typically administered in 100–250 mL vials or bags. Dipeptiven® by Fresenius Kabi is a leading brand in the EU, widely used in critical care, oncology, and surgical patients. In the US, it is often integrated into custom TPN formulations. Pharma B2B suppliers offer GMP-compliant bulk sourcing of L-Alanyl-L-Glutamine to hospitals and nutrition support providers across global markets.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.